Bendoy, Lowila L.
HRN: 06-41-15 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/16/2023
CEFUROXIME 1.5GM (VIAL)
09/16/2023
09/17/2023
IV
1.5gms
Q8hrs
S/P TAH
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes